Dr. Erkut Borazanci is a medical oncologist and clinical investigator at the Virginia G. Piper Cancer Center at HonorHealth Research Institute. Dr. Borazanci is also the medical director of the molecular medicine institute at HonorHealth and holds adjunct appointments as clinical assistant professor at the Translational Genomics Research Institute (TGen) and University of Arizona. Dr. Borazanci obtained his masters of science in molecular biology and biochemistry at Louisiana State University Health. He completed medical school, internal medicine, and oncology fellowship at LSU Health Shreveport and was recruited as the drug development scholar from 2013 to 2015. His specialty is gastrointestinal oncology, particularly pancreatic cancer, and has had the privilege to work closely with leaders in the field including Dr. Dan Von Hoff and Dr. Ramesh Ramanathan. He was invited to the 2014 AACR/ASCO Workshop Methods in Clinical Cancer Research. Dr. Borazanci is the principal investigator for several clinical trials, many of which are phase I and are first in human studies. HonorHealth Research Institute has closely worked with TGen along with several collaborators to bring new and promising agents to offer as treatment options at the Virginia G. Piper Cancer Center on the HonorHealth Shea Campus.
